Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Tiragolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 12 Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Melanoma 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Tumors 1 Solid Tumor, Adult 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma 1 PD-L1-selected Solid Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Follicular 1

Interventions

Paclitaxel 94 Carboplatin 76 pembrolizumab 70 Cisplatin 28 Bevacizumab 27 Surveys and Questionnaires 23 Radiotherapy 22 Letrozole 22 Megestrol Acetate 20 Doxorubicin 20 olaparib 19 lenvatinib 18 Taxes 17 Specimen Handling 17 Docetaxel 17 Nivolumab 16 Magnetic Resonance Spectroscopy 16 dostarlimab 15 Metformin 14 Blood Specimen Collection 13 Biopsy 13 durvalumab 12 Observation 12 Medroxyprogesterone Acetate 12 Gemcitabine 12 Trastuzumab 11 Indocyanine Green 11 Fulvestrant 11 temsirolimus 10 Brachytherapy 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04486352 2026-04-01

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡